MedPath

Pfizer Pharmaceuticals Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

PHILIPPINES:27
NMPA:9

Drug Approvals

Glipizide Extended Release Tablets

Product Name
瑞易宁
Approval Number
J20160045
Approval Date
Feb 22, 2019
NMPA

Glipizide Extended Release Tablets

Product Name
瑞易宁
Approval Number
国药准字J20160045
Approval Date
Feb 22, 2019
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
J20171065
Approval Date
Sep 27, 2017
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
J20171063
Approval Date
Sep 27, 2017
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
国药准字J20171063
Approval Date
Sep 27, 2017
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
国药准字J20171062
Approval Date
Sep 27, 2017
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
国药准字J20171065
Approval Date
Sep 27, 2017
NMPA

Atorvastatin Calcium Tablets

Product Name
立普妥
Approval Number
J20171062
Approval Date
Sep 27, 2017
NMPA

Azithromycin

Product Name
阿奇霉素
Approval Number
H20150105
Approval Date
Feb 13, 2015
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.